Strong sales growth for Polynovo (ASX:PNV) underpins share price gains

Shares in med-tech developer Polynovo (ASX:PNV) have doubled in the past year, driven by surging sales in its patented Novosorb product. More recently, the company revealed its first “million dollar month”, with sales for April ostensibly bringing the business to break-even on a monthly basis. What does the business do? Continue Reading